E. Shin

Arginine 65 methylation of Neurogenin 3 by PRMT1 is a prerequisite for development of hESCs into pancreatic endocrine cells

Yong-Mahn Han, Jieun Choi, Hail Kim, 2022, bioRxiv.

Directed evolution of CRISPR-Cas9 to increase its specificity

Daesik Kim, Eunji Shin, Kangin Lee, 2017, Nature Communications.

NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer

J. Lee, Jeong-Sun Seo, Jong-Yeon Shin, 2015, Oncotarget.

Directed evolution of CRISPR-Cas9 to increase its specificity

Kangin Lee, Jin-Soo Kim, Daesik Kim, 2017, bioRxiv.

MHC Class I Enables MSCs to Evade NK-Cell-Mediated Cytotoxicity and Exert Immunosuppressive Activity.

Kangin Lee, J. Oh, H. Kim, 2022, Stem cells.

SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington’s disease

Jihwan Song, Seokjoong Kim, K. Lee, 2022, NPJ Regenerative medicine.

ECM Architecture-Mediated Regulation of β-Cell Differentiation from hESCs via Hippo-Independent YAP Activation.

Youngbin Cho, E. Shin, Yong-Mahn Han, 2022, ACS biomaterials science & engineering.

CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model.

B. Chung, Chul-woo Yang, S. Lim, 2023, Translational research : the journal of laboratory and clinical medicine.

Arginine 65 methylation of Neurogenin 3 by PRMT1 is required for pancreatic endocrine development of hESCs

Yong-Mahn Han, Jieun Choi, Hail Kim, 2023, Experimental & molecular medicine.